These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2720893)

  • 21. PALA, vindesine, and cisplatin combination chemotherapy in advanced malignant melanoma. A pilot study.
    Voigt H; Kleeberg UR
    Cancer; 1984 May; 53(10):2058-62. PubMed ID: 6231091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A clinical trial of intravenous vinorelbine tartrate plus tamoxifen in the treatment of patients with advanced malignant melanoma.
    Feun LG; Savaraj N; Hurley J; Marini A; Lai S
    Cancer; 2000 Feb; 88(3):584-8. PubMed ID: 10649251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coumarin and cimetidine in malignant melanoma.
    Thornes RD; Lynch G; Sheehan MV
    Ir Med J; 1983 Jan; 76(1):53. PubMed ID: 6826342
    [No Abstract]   [Full Text] [Related]  

  • 24. Phase II multicentre study of temozolomide in combination with interferon alpha-2b in metastatic malignant melanoma.
    García M; del Muro XG; Tres A; Crespo C; Valladares M; López JJ; Rifà J; Pérez X; Filipovich E; Germà-Lluch JR
    Melanoma Res; 2006 Aug; 16(4):365-70. PubMed ID: 16845333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A sequential four-drug chemotherapy and biotherapy with interferon alpha and GM-CSF--an innovative protocol for the treatment of metastatic melanoma.
    Schachter J; Rakowsky E; Sulkes A; Adler A
    Cancer Biother Radiopharm; 1998 Jun; 13(3):155-64. PubMed ID: 10850351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase-II trial of combination treatment of interferon-α, cimetidine, cyclooxygenase-2 inhibitor and renin-angiotensin-system inhibitor (I-CCA therapy) for advanced renal cell carcinoma.
    Tatokoro M; Fujii Y; Kawakami S; Saito K; Koga F; Matsuoka Y; Iimura Y; Masuda H; Kihara K
    Cancer Sci; 2011 Jan; 102(1):137-43. PubMed ID: 20973869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I trial of sorafenib in combination with IFN alpha-2a in patients with unresectable and/or metastatic renal cell carcinoma or malignant melanoma.
    Escudier B; Lassau N; Angevin E; Soria JC; Chami L; Lamuraglia M; Zafarana E; Landreau V; Schwartz B; Brendel E; Armand JP; Robert C
    Clin Cancer Res; 2007 Mar; 13(6):1801-9. PubMed ID: 17363536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of fibroblast interferon (HuIFN beta), carboxamide (DTIC), and cimetidine for advanced malignant melanoma.
    Abdi EA; McPherson TA; Tan YH
    J Biol Response Mod; 1986 Oct; 5(5):423-8. PubMed ID: 3772395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma. A multicenter phase II study of the Italian Cooperative Oncology Group.
    Daponte A; Ascierto PA; Gravina A; Melucci MT; Palmieri G; Comella P; Cellerino R; DeLena M; Marini G; Comella G;
    Cancer; 2000 Dec; 89(12):2630-6. PubMed ID: 11135225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metronomic oral low-dose treosulfan chemotherapy combined with cyclooxygenase-2 inhibitor in pretreated advanced melanoma: a pilot study.
    Spieth K; Kaufmann R; Gille J
    Cancer Chemother Pharmacol; 2003 Nov; 52(5):377-82. PubMed ID: 12879280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pilot study of low-dose thalidomide and interferon alpha-2b in patients with metastatic melanoma who failed prior treatment.
    Solti M; Berd D; Mastrangelo MJ; Sato T
    Melanoma Res; 2007 Aug; 17(4):225-31. PubMed ID: 17625452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I/II study of a cisplatin-taxol-dacarbazine regimen in metastatic melanoma.
    Papadopoulos NE; Bedikian A; Ring S; Kim KB; Hwu WJ; Gerber DL; Homsi J; Hwu P
    Am J Clin Oncol; 2009 Oct; 32(5):509-14. PubMed ID: 19506454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential dacarbazine chemotherapy followed by recombinant interleukin-2 in metastatic melanoma. A pilot multicentre phase I-II study.
    Shiloni E; Pouillart P; Janssens J; Splinter T; Di Peri T; Symann M; Roest GJ; Palmer PA; Franks CR
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 3():S45-9. PubMed ID: 2697579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose cyclophosphamide and low-dose interleukin-2 for malignant melanoma.
    Mitchell MS; Kempf RA; Harel W; Shau H; Boswell WD; Lind S; Dean G; Moore J; Bradley EC
    Bull N Y Acad Med; 1989 Jan; 65(1):128-44. PubMed ID: 2532554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paclitaxel and tamoxifen: An active regimen for patients with metastatic melanoma.
    Nathan FE; Berd D; Sato T; Mastrangelo MJ
    Cancer; 2000 Jan; 88(1):79-87. PubMed ID: 10618609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: a prospective study.
    Franciosi V; Cocconi G; Michiara M; Di Costanzo F; Fosser V; Tonato M; Carlini P; Boni C; Di Sarra S
    Cancer; 1999 Apr; 85(7):1599-605. PubMed ID: 10193952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase I trial of concurrent twice-weekly recombinant human interleukin-12 plus low-dose IL-2 in patients with melanoma or renal cell carcinoma.
    Gollob JA; Veenstra KG; Parker RA; Mier JW; McDermott DF; Clancy D; Tutin L; Koon H; Atkins MB
    J Clin Oncol; 2003 Jul; 21(13):2564-73. PubMed ID: 12829677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose chemotherapy without autologous bone marrow transplantation in melanoma.
    Tchekmedyian NS; Tait N; Van Echo D; Aisner J
    J Clin Oncol; 1986 Dec; 4(12):1811-8. PubMed ID: 3537218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in metastatic malignant melanoma.
    Planting AS; van der Burg ME; Goey SH; Schellens JH; Vecht C; de Boer-Dennert M; Stoter G; Verweij J
    Eur J Cancer; 1996 Oct; 32A(11):2026-8. PubMed ID: 8943692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.